Search

Your search keyword '"Haberlova, Jana"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Haberlova, Jana" Remove constraint Author: "Haberlova, Jana"
Sorry, I don't understand your search. ×
42 results on '"Haberlova, Jana"'

Search Results

1. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders

2. 2024 update: European consensus statement on gene therapy for spinal muscular atrophy

3. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders

4. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

5. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

7. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

10. 2024 update: European consensus statement on gene therapy for spinal muscular atrophy

11. EURO-NMD registry:federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders

12. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

13. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy

16. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients

18. Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy

19. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies:a large international cohort

21. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy

22. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies

23. Mapping the differences in care for 5,000 Spinal Muscular Atrophy patients, a survey of 24 national registries in North America, Australasia and Europe

26. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

27. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

28. Response to letter: A decision for life – Treatment decisions in newly diagnosed families with spinal muscular atrophy

29. genetic diagnosis; limb-girdle weakness; neuromuscular disease; next-generation sequencing; targeted exome analysisweakness

30. Hereditary Spastic Paraplegia 3A Associated With Axonal Neuropathy

31. Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2

32. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

34. Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen

35. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies

36. Loss of function mutations inHARScause a spectrum of inherited peripheral neuropathies

37. Mapping the differences in care for 5,000 Spinal Muscular Atrophy patients, a survey of 24 national registries in North America, Australasia and Europe

38. HomozygousEXOSC3Mutation c.92G→C, p.G31A is a Founder Mutation Causing Severe Pontocerebellar Hypoplasia Type 1 Among the Czech Roma

39. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies.

40. SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve

41. Homozygous EXOSC3 Mutation c.92G→C, p.G31A is a Founder Mutation Causing Severe Pontocerebellar Hypoplasia Type 1 Among the Czech Roma.

42. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies

Catalog

Books, media, physical & digital resources